Risk factor analysis for survival and graft versus host disease in patients with chronic myelogenous leukemia submitted to allogeneic bone marrow transplantation.

被引：0
|
作者：
Moreira, VA [1 ]
Oliveira, FAM [1 ]
Pasquini, R [1 ]
de Medeiros, CR [1 ]
机构：
[1] Univ Fed Parana, Bone Marrow Transplantat Serv, BR-80060000 Curitiba, Parana, Brazil
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4950
引用
收藏
页码：385B / 385B
页数：1
相关论文
共 50 条
  • [1] Acute graft versus host disease: A statistical analysis of risk factor in 36 patients submitted to allogeneic bone marrow transplantation.
    Damiani, D
    BLOOD, 1999, 94 (10) : 366B - 367B
  • [2] HEMARTHROSIS AS GRAFT VERSUS HOST DISEASE IN A PATIENT AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CASE REPORT)
    Teplyakova, O.
    Dotsenko, T.
    Shlykova, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1214 - 1215
  • [3] Elimination of leukemia in the absence of lethal graft versus host disease after allogeneic bone marrow transplantation.
    Drobyski, WR
    Gendelman, M
    Vodanovic-Jankovic, S
    Gorski, J
    BLOOD, 2002, 100 (11) : 819A - 819A
  • [4] Eosinophilia as a presenting sign for chronic graft versus host disease after allogeneic bone marrow transplantation.
    Hsu, Y
    Cohen, A
    Couriel, DR
    BLOOD, 2003, 102 (11) : 462B - 462B
  • [5] ABUNDANT MACROPHAGE GROWTH IN CULTURE FROM PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA - A RISK FACTOR FOR GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION
    NISSEN, C
    GRATWOHL, A
    TICHELLI, A
    SPECK, B
    EXPERIENTIA, 1988, 44 (02): : 167 - 169
  • [6] Membranous nephropathy and chronic graft-versus-host disease in patients with allogeneic bone marrow transplantation
    Mandreoli, M
    Casanova, S
    Bonifazi, F
    Bandini, G
    Santoro, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 288A - 288A
  • [7] IMPROVED SURVIVAL OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    MOREB, J
    JOHNSON, T
    KUBILIS, P
    MYERS, L
    OBLON, D
    MILLER, A
    ELFENBEIN, G
    WEINER, R
    AMERICAN JOURNAL OF HEMATOLOGY, 1995, 50 (04) : 304 - 306
  • [8] ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA - GRAFT-VERSUS-HOST-DISEASE AND GRAFT-VERSUS-LEUKEMIA-EFFECT
    KOLB, HJ
    BENDERGOTZE, C
    HAAS, RJ
    WILMANNS, W
    THIERFELDER, S
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1986, 128 (40): : 679 - 684
  • [9] Immuneprophylaxis of graft versus host disease in chronic myeloid leukemia patients submitted to allogeneic bone marrow transplantation: Comparison between 3 and 4 doses of methotrexate.
    deMedeiros, CR
    ZanisNeto, J
    Bitencourt, MA
    Friedrich, ML
    Bonfim, CM
    Ogasawara, VS
    Almeida, PT
    Pasquini, R
    BLOOD, 1997, 90 (10) : 4400 - 4400
  • [10] Risk factors for acute graft versus host disease following allogeneic non-myeloablative bone marrow transplantation.
    George, RT
    Sykes, M
    Spitzer, TR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S374 - S375
12345